共 228 条
[1]
Foran JM(2000)Treatment of mantle-cell lymphoma with rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response Ann Oncol 11 117-21
[2]
Cunningham D(2010)Mantle cell lymphoma: report of the 2009 mantle cell lymphoma consortium workshop Leuk Lymphoma 51 390-8
[3]
Coiffier B(2014)Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT) Ann Oncol 25 1053-8
[4]
Solal-Celigny P(2006)Expression of the cyclin-dependent kinase inhibitor p27 and its deregulation in mouse B cell lymphomas Leuk Res 30 153-63
[5]
Reyes F(2008)Advances in the understanding of mantle cell lymphoma Br J Haematol 142 149-65
[6]
Ghielmini M(2013)CCND2 rearrangements are the most frequent genetic events in cyclin D1(−) mantle cell lymphoma Blood 121 1394-402
[7]
Williams ME(2006)Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2 Pathol Int 56 440-8
[8]
Dreyling MH(2005)Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling Blood 106 4315-21
[9]
Kahl BS(2013)Cyclin D1-negative mantle cell lymphoma Blood 121 1249-50
[10]
Leonard JP(2003)Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation Blood 102 1588-94